A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy

Summary

The purpose of this study is to determine the safety and efficacy of various doses of AND017 after 6 weeks of treatment in subjects with anemia of cancer who are not receiving chemotherapy.

Timeline

Start

2027-12

Primary completion

2028-05

Completion

2028-08

Drugs

Indications